James S. Hanson

James S. Hanson (board member) discloses dealings in 2 companies, chiefly Fortrea Holdings Inc. and G1 Therapeutics, Inc. We count 19 filings; the first trade dates from 10 December 2018 and the latest from 9 September 2025.

Market trades split into 4 purchases (€104k) and 6 sales (€58k). On balance, insiders were net buyers of €46k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants and 4 option exercises. So far in 2025, the count stands at no purchases and 3 sales.

The median purchase comes to €22k. Clusters matter here: 3 out of 4 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

On 10 September 2025 came the latest disclosure, an open-market sale for €15k in Fortrea Holdings Inc. The clock since the last published purchase (12 June 2024) now reads 863 days. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.